2nd Quarter - Amendment
SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)
Income
—
Expenses
$813,700
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Amendment | Nov 17, 2008 | $41,745 | Replaced |
| 2nd Quarter - Report | Mar 26, 2009 | $482,349 | Replaced |
| 2nd Quarter - Amendment (this page) | Aug 31, 2009 | $813,700 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
reimbursement issues relating to Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| TIM HERMES | — |
| MARK WANDA | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.